Commonwealth Equity Services’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Sell |
140,066
-1,056
| -0.7% | -$9.46K | ﹤0.01% | 2374 |
|
|
2025
Q1 | $1.06M | Buy |
141,122
+1,990
| +1% | +$14.9K | ﹤0.01% | 2408 |
|
|
2024
Q4 | $1.05M | Sell |
139,132
-3,567
| -2% | -$26.8K | ﹤0.01% | 2348 |
|
|
2024
Q3 | $1.09M | Sell |
142,699
-1,175
| -0.8% | -$8.93K | ﹤0.01% | 2285 |
|
|
2024
Q2 | $889K | Sell |
143,874
-1,450
| -1% | -$8.96K | ﹤0.01% | 2376 |
|
|
2024
Q1 | $738K | Sell |
145,324
-120
| -0.1% | -$609 | ﹤0.01% | 2476 |
|
|
2023
Q4 | $871K | Sell |
145,444
-16,640
| -10% | -$99.7K | ﹤0.01% | 2271 |
|
|
2023
Q3 | $1.15M | Hold |
162,084
| – | – | ﹤0.01% | 1983 |
|
|
2023
Q2 | $1.14M | Buy |
162,084
+1,485
| +0.9% | +$10.5K | ﹤0.01% | 2003 |
|
|
2023
Q1 | $1.34K | Buy |
160,599
+5,900
| +4% | +$49 | ﹤0.01% | 1839 |
|
|
2022
Q4 | $1.78M | Sell |
154,699
-12,831
| -8% | -$147K | ﹤0.01% | 1580 |
|
|
2022
Q3 | $2.11M | Buy |
167,530
+170
| +0.1% | +$2.14K | 0.01% | 1380 |
|
|
2022
Q2 | $1.77M | Sell |
167,360
-5,932
| -3% | -$62.7K | ﹤0.01% | 1506 |
|
|
2022
Q1 | $2.82M | Buy |
173,292
+2,485
| +1% | +$40.4K | 0.01% | 1274 |
|
|
2021
Q4 | $2.37M | Buy |
170,807
+50,584
| +42% | +$700K | 0.01% | 1389 |
|
|
2021
Q3 | $1.73M | Sell |
120,223
-576
| -0.5% | -$8.27K | ﹤0.01% | 1526 |
|
|
2021
Q2 | $1.91M | Sell |
120,799
-2,660
| -2% | -$42K | ﹤0.01% | 1453 |
|
|
2021
Q1 | $1.26M | Buy |
123,459
+5,004
| +4% | +$50.9K | ﹤0.01% | 1639 |
|
|
2020
Q4 | $882K | Sell |
118,455
-1,441
| -1% | -$10.7K | ﹤0.01% | 1729 |
|
|
2020
Q3 | $411K | Buy |
119,896
+7,400
| +7% | +$25.4K | ﹤0.01% | 2108 |
|
|
2020
Q2 | $536K | Buy |
112,496
+12,884
| +13% | +$61.4K | ﹤0.01% | 1834 |
|
|
2020
Q1 | $199K | Buy |
99,612
+14,932
| +18% | +$29.8K | ﹤0.01% | 2397 |
|
|
2019
Q4 | $292K | Buy |
84,680
+26,950
| +47% | +$92.9K | ﹤0.01% | 2336 |
|
|
2019
Q3 | $165K | Buy |
57,730
+4,500
| +8% | +$12.9K | ﹤0.01% | 2596 |
|
|
2019
Q2 | $201K | Buy |
53,230
+9,900
| +23% | +$37.4K | ﹤0.01% | 2505 |
|
|
2019
Q1 | $352K | Hold |
43,330
| – | – | ﹤0.01% | 2022 |
|
|
2018
Q4 | $349K | Hold |
43,330
| – | – | ﹤0.01% | 1913 |
|
|
2018
Q3 | $330K | Hold |
43,330
| – | – | ﹤0.01% | 2088 |
|
|
2018
Q2 | $248K | Sell |
43,330
-200
| -0.5% | -$1.15K | ﹤0.01% | 2291 |
|
|
2018
Q1 | $207K | Buy |
43,530
+600
| +1% | +$2.85K | ﹤0.01% | 2376 |
|
|
2017
Q4 | $211K | Buy |
42,930
+1,275
| +3% | +$6.27K | ﹤0.01% | 2327 |
|
|
2017
Q3 | $218K | Buy |
41,655
+900
| +2% | +$4.71K | ﹤0.01% | 2206 |
|
|
2017
Q2 | $227K | Buy |
40,755
+800
| +2% | +$4.46K | ﹤0.01% | 2137 |
|
|
2017
Q1 | $336K | Sell |
39,955
-300
| -0.7% | -$2.52K | ﹤0.01% | 1776 |
|
|
2016
Q4 | $255K | Hold |
40,255
| – | – | ﹤0.01% | 1882 |
|
|
2016
Q3 | $178K | Hold |
40,255
| – | – | ﹤0.01% | 2020 |
|
|
2016
Q2 | $114K | Buy |
40,255
+5,450
| +16% | +$15.4K | ﹤0.01% | 2082 |
|
|
2016
Q1 | $98K | Buy |
34,805
+5,300
| +18% | +$14.9K | ﹤0.01% | 2058 |
|
|
2015
Q4 | $304K | Buy |
29,505
+3,800
| +15% | +$39.2K | ﹤0.01% | 1597 |
|
|
2015
Q3 | $293K | Buy |
25,705
+800
| +3% | +$9.12K | ﹤0.01% | 1558 |
|
|
2015
Q2 | $372K | Sell |
24,905
-320
| -1% | -$4.78K | ﹤0.01% | 1508 |
|
|
2015
Q1 | $228K | Buy |
25,225
+50
| +0.2% | +$452 | ﹤0.01% | 1810 |
|
|
2014
Q4 | $306K | Sell |
25,175
-3,320
| -12% | -$40.4K | ﹤0.01% | 1562 |
|
|
2014
Q3 | $279K | Sell |
28,495
-62,028
| -69% | -$607K | ﹤0.01% | 1597 |
|
|
2014
Q2 | $1.15M | Buy |
90,523
+47,200
| +109% | +$602K | 0.01% | 792 |
|
|
2014
Q1 | $458K | Buy |
43,323
+24,300
| +128% | +$257K | 0.01% | 1226 |
|
|
2013
Q4 | $145K | Sell |
19,023
-250
| -1% | -$1.91K | ﹤0.01% | 1769 |
|
|
2013
Q3 | $140K | Buy |
19,273
+2,650
| +16% | +$19.3K | ﹤0.01% | 1713 |
|
|
2013
Q2 | $26K | Buy |
+16,623
| New | +$26K | ﹤0.01% | 1773 |
|